Ignite Creation Date:
2024-05-06 @ 3:46 AM
Last Modification Date:
2024-10-26 @ 11:39 AM
Study NCT ID:
NCT02376699
Status:
TERMINATED
Last Update Posted:
2023-05-01
First Post:
2015-02-17
Brief Title:
Safety Study of SEA-CD40 in Cancer Patients
Sponsor:
Seagen Inc
Organization:
Seagen Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Carcinoma Non-Small-Cell Lung |
| Carcinoma Squamous Cell |
| Hodgkin Disease |
| Lymphoma |
| Lymphoma B-Cell |
| Lymphoma Follicular |
| Lymphoma Large B-Cell Diffuse |
| Melanoma |
| Neoplasm Metastasis |
| Neoplasms Head and Neck |
| Neoplasms Squamous Cell |
| Non-Small Cell Lung Cancer |
| Non-Small Cell Lung Cancer Metastatic |
| Non-small Cell Carcinoma |
| Squamous Cell Cancer |
| Squamous Cell Carcinoma |
| Squamous Cell Carcinoma of the Head and Neck |
| Squamous Cell Neoplasm |
| Lymphoma Non-Hodgkin |
| Pancreatic Adenocarcinoma |
Keywords:
| Name | View |
|---|---|
| Seattle Genetics | View |
| CD40 Antigen | View |
| Drug Therapy | View |
| Follicular Lymphoma | View |
| Hodgkin Disease | View |
| Immunotherapy | View |
| Indolent Lymphoma | View |
| Lymphoma | View |
| Lymphoma B-Cell | View |
| Lymphoma Large B-Cell Diffuse | View |
| Lymphoma Non-Hodgkin | View |
| Monoclonal Antibody | View |
| Neoplasms | View |
| Neoplasm Metastasis | View |
| Solid tumor | View |